Introduction: About 15 million babies are born preterm
care. The duration of intervention will be five out of seven days. Neonatal behavioural assessment scale (NBAS) will be performed at baseline and then on the 7th day to ascertain the intervention effectiveness. Results: Data analysis will be done by Wilcoxon signed rank test/paired t-test and Mann Whitney U test/independent t-test will be done to compare the pre and post intervention score of NBAS within and between groups.
The level of significance will be set as p<0.05. Conclusion:
Introduction
A neonate is a baby under 28 days or 4 weeks of age whilst a neonate born in less than 37 weeks of gestation is a preterm neonate 1 and is considered a high-risk neonate as they are prone to delayed growth and development, mental and physical disability, life time disability such as learning disability, visual or hearing impairments, or even increased risk of death 2, 3, 4 . The preterm new born moves to smaller degrees as compared to full term newborns 5 . In high risk neonates there are increased chances of appearance of development impairments at later stage of development 6, 7, 8 . Stimulation given at an early stage to neonates can alter the growth of the brain cells, improve adaptive behaviour, and thus age appropriate development is likely to be achieved 6 .
Yakson is a Korean therapeutic touch given to neonates and infants by caressing their abdomen with one hand while the other hand is placed on the back of the neonate to relieve their pain and to calm them down. It was traditionally used by Koreans by caressing the aching body part of their children with a belief that it would relieve their pain 2 . Yakson is one of the most effective and safe methods of tactile stimulation for preterm neonates 2, 8 . Tactile and kinaesthetic stimulation techniques (such as massage and rhythmic passive limb movements) have proven to be effective on preterm neonate's development but there is no standardized protocol for these interventions. Therefore there is need to describe the methodology as well as the effects accurately 9 . The role of physiotherapy interventions in treatment of high risk neonates has not been established 10, 11, 12 . The high risk neonates are prone to developmental delays with early intervention being the most effective for them owing to the plasticity of brain in early infancy 5, 6 .
Pepinoa and Mezzacappa concluded that tactile kinaesthetic stimulation is a promising technique potentially associated with faster weight gain, shorter hospital stay, and better behavior, among others, but there is no standard protocol for its application 9 . Aliabadi and Askary examined the effects of tactile-kinaesthetic stimulation on the physical and behavioural development of infants with low birth weight (LBW) (>1500g and <2499g). They found that tactile-kinesthetic stimulation did not have any adverse physiological effects on the physiological parameters and helped in improvement of adaptive behaviour of the LBW infants 6 . Kachoosangy and Aliabadi stated that tactile kinaesthetic stimulation is effective in improving the motor behaviour, but suggested that there is need for studies in other aspects of behaviour in LBW infants 13 .
Ferreira and Bergamasco concluded that tactile and kinaesthetic stimulation had a positive effect on adjustment and self-regulation behaviour of preterm neonates 14 . They implied the need for studies that will focus on the effects of these interventions. Eshghi The present study is aimed at determining the combined effects of tactile stimulation in the form of Yakson touch and kinaesthetic stimulation in the form of passive movements on LBW neonates (<2500gm) and preterm neonates (<37 weeks) through a RCT.
Material and Methods
The study design will be a single-blinded RCT of two-group pretest-post test design 16 . This single centre study will be conducted within the NICU, Department of Paediatrics of a recognized tertiary care teaching hospital. Parents of infants born prematurely and with LBW will be approached for consent prior to their child being randomly allocated into one of two groups -an intervention group or the 'usual care' control group. Parents of all the potential participants will receive a written explanation of the trial and given written informed consent forms to be signed prior to their child being involved in the trial. Once parental consent is obtained, samples will be recruited via simple random sampling method using a random number generator, an application provided by the Statistical Package for Social Sciences (SPSS version 16. SPSS Inc., Chicago, IL, USA.)
Participant's recruitment, interventions and outcomes: Recruitment for this study will be undertaken for a total duration of 1 year between June, 2016 and May, 2017. Neonates of either gender with birth weight less than 2500 grams and born before 37 weeks of gestation will be recruited into the study in the fi rst week of their life. Medically unstable neonates requiring lifesaving interventions such as assisted ventilation, cardiac support medicines etc. or neonates with communicable disease or congenital anomaly or skin infection will be excluded from the study. After randomization each neonate will receive their allocated interventions once a day for 1 week (5 days a week) for 25 minutes a day after the random allocation.
Yakson touch and kinaesthetic stimulation will constitute the independent variables while the dependent variable will be development of neonates as per the scores of NBAS. Outcomes of the study will be measured by the qualifi ed primary researcher in terms of the NBAS at baseline and end of 1 week intervention. The primary researcher had undertaken suffi cient training in completing the NBAS on neonates before study commencement. The detailed schematic diagram of the study protocol is displayed in Figure 1 .
Sample size: Sample size has been estimated on the basis of unpublished pilot study data. The formula for sample size is comparison of means of two-sample parallel design study 17 , n= 2 [(Zα+Zβ)s/d]² (where Zα = level of signifi cance, Zβ = power of study, s = pooled SD of the two samples, d = minimal clinically important difference (MCID) for NBAS total score based on our pilot study. Zα is set as 1.98, as α will be assumed to be 0.05 to greatly minimize type 1 error. Zβ is 0.84 and thereby maintaining the power of the study at 80%. From the pilot study, the following have been obtained s = 18.9 and d = 20.9. Thus a sample size of 14 in each group considering 10% dropout rate, has been determined.
Assignment of intervention:
Neonates meeting the inclusion criteria for the study will be identifi ed and following parental consent will be randomly allocated to one of two groups: A -the experimental group (n=14), or B -the control group (n=14), Figure 1 . By the block randomization method, the neonates will be randomly allocated using sequentially numbered, opaque sealed, envelopes. The parents of the neonates will be instructed not to reveal the allocated groups of their baby until the study begins. An independent associate investigator who is not involved in the study intervention delivery will generate the allocation sequence, enrol the participants, and assign participants to their allocated group. As the primary researcher is a post-graduate student and the study will be undertaken as a part of her curriculum, blinding during recruitment, intervention and data collection phases will not be possible. Data analysis will be performed by a blinded independent researcher. Universal precautions to maintain sterile conditions will be taken.
ii. Then the therapist will warm both hands with a radiant warmer so that the temperature of the palms reaches between 93F and 94F (33.9-34.4°C). Digital thermometer will be used to check the temperature of palms. By energy loss or decay mechanism, it is not uncommon to observe decay or loss of heat from palm. Heat loss is inevitable during the application of Yakson touch through palms. But as the radiant warmer will be in on state when executing the intervention, the energy loss would be minimal.
iii. The therapist will relax arms and shoulder muscles for 1 minute and will do deep breathing to accumulate Ki energy on the palms.
iv. The therapist will apply Yakson to the neonate with the neonate being in supine position. Yakson will be given for 15 minutes which will be divided into resting the hands, caressing gently, and again resting the hands, each of which will last for 5 minutes. Throughout the application of Yakson, fi ngers and palm of the therapist will be in constant contact and the contact will be such that there is no pressure on the infant.
v.
Resting the hands for 5 minutes-while one hand is resting on the chest and abdomen of the neonate and other hand is supporting the back, the therapist will concentrate on resting hands assuming that a healthy Ki energy is passing to the neonate. During this, the therapist will do slow breathing to remain relaxed.
vi. Caressing gently for 5 minutes-with hand in same position, the therapist will caress repeatedly for 5 minutes. Therapist will caress for 1 minute, rest for 30 seconds, caress for 1 minute, rest for 30 seconds and caress for 2 minutes. The therapist will caress the abdomen and chest of the infant in clockwise direction in a diameter of 1 centimetre in circular motion every 10 seconds vii. Resting the hands for 5 minutes-the therapist will rest the hands as previously described.
Kinaesthetic stimulation: Immediately following the Yakson, for giving kinaesthetic stimulation the neonate will remain in supine position. There will be six passive fl exion and extension movements per limb. Each of the movement will each last for approximately 10 seconds. The movements will be performed in the following order: right arm, left arm, right leg, left leg and both legs simultaneously involving full range of motion in major joints like shoulder and hip joints.
Control group treatment:
The neonates in the control group will receive Kangaroo mother care18 for one hour a day and developmental positioning (positioning of preterm infants for optimal physiological development) for 20 minutes per hour for 5 days.
Data collection: The NBAS will be used to monitor the effects of YAKIN on the development of high risk neonates. Baseline reading of NBAS will be recorded for all enrolled neonates before the beginning of intervention. The NBAS is an instrument designed to assess full-term babies from 37-48 weeks' gestation with excellent test-retest reliability; it has been used in over 700 studies worldwide, as a systematic way of observing the individual baby's responses to moderately aversive (e.g. refl exes, motor tone) and non-aversive (e.g. tracking, turning to sound) stimulation. The NBAS contains 28 behavioural items, 18 refl ex items, and 7 supplementary items for fragile or high-risk infants. It is a neurobehavioral screening tool, and will identify gross abnormalities or asymmetries. All items will be administered when the baby is in the appropriate behavioural state (states 1-6, from deep sleep to crying), and there is a sequence to follow. The NBAS is a structured examination to demonstrate both negative and positive characteristics of infant's behavior. The motor system in NBAS includes the general tone, motor maturity, pull-to-sit, defensive, and activity level 19 . There are six main clusters ⁄ packages scored 1-9 (28 items), seven supplementary items scored 1-9, and 18 refl ex ⁄ motor items scored 0-3 20 . The scoresheet includes 27 behavioral items, each of which is scored on a nine point scale, each of which is scored on a three point scale 21 . Time taken in administration is 20-30 minutes. It is a naturalistic observation, elicited items and handling required administered according to infant's state 20 .
The The domains are habituation, social interactive, motor system, state organization, state regulation, autonomic system, supplementary system and refl exes 19 .
To minimize dropouts and to facilitate participant retention, parent of the neonates will be assured 30% fee concession towards paediatric physiotherapy consultation. They will be reminded of the physiotherapy visits over Short Messaging Services (SMS) and if their visits were delayed by two days, then telephonic followup would be done.
To ensure confi dentiality each participant will be assigned a serial code for data collection and analysis; for example, C1 for control group fi rst participants and E1 for the fi rst participant in the experimental group. The primary investigator will be the only person to hold the key to the code linking participant details and their data. The data will be entered in the Microsoft® Offi ce Excel 2010 using encrypted user password. Moreover, the data will be stored in desktop with no internet connection and sealed Universal Serial Bus (USB) port. This will prevent unauthorized data access and data theft. The fi nal data will also be stored on a non-rewritable Compact Disc Read-only Memory (CD-ROM), again with encrypted user password. All the encrypt user password will be shared between the primary researcher and the data analyst only. Data will be archived for future reference without names or any other features which can reveal the participant identities.
Data and Safety Monitoring Committee: Data collected will be overseen by the Data and Safety Monitoring Committee (DSMC), which is headed by the Chairman of the Student Project Committee. It is independent from the primary researcher and has its role in monitoring the outcome of the intervention and to alert the researcher if any adverse results such as more than 20% declining tendency from NBAS baseline score occurs. Interim analyses will be performed, when atleast 50% of neonates have been randomized, to check whether the effect of intervention is proceeding as expected or not and to document other unintended effects of trial interventions. If any pre-determined adverse events occur (such as SPO2 < 89, 100 > HR > 200 beats/min, etc.) then cessation of study protocol guidelines will be strictly adhered to. It has been fi xed that DSMC will audit the trial conduct once in 15 days by an independent statistician. The date and time of the audit will not be disclosed to the primary researcher.
The data will be collected, entered and analysed by the primary researcher. Either the Wilcoxon signed rank test or a paired t-test will be used to compare the pre and post intervention score of the NBAS, depending on whether the data are normally distributed or not. Similarly, a Mann Whitney U test or an independent t-test will be used to compare the NBAS scores of experimental group and control group. Data will be analysed using the statistical software (SPSS version 16. SPSS Inc., Chicago, IL, USA.). Level of signifi cance will be set as 0.05. Missing data due to unavoidable causes will be managed by intention-to-treat (ITT) analysis 22, 23 .
Discussion
A preterm neonate in NICU is deprived of what a term neonate gets, that is touch of his mother and is exposed to various noxious and aversive stimuli like heel prick handling by the NICU staff whose touch is unknown to them. Therefore Yakson touch might prove to have a soothing and calming effect on neonate behaviour, improve their sleep status and have a positive effect on social development of neonates 2, 8, 24 . Also kinaesthetic stimulation should be included in early intervention program to promote adaptive motor behaviour of neonates with LBW 6,13 .
Pederson et al examined the motor function of LBW preterm infants to predict developmental delays which may appear later and found that low birthweight infants exhibit different pattern of motor development in their fi rst year of life as compared to full term infants 24 . Mahoney and Cohen in their review article concluded that there are evidences that early intervention assists the infants in age appropriate development 7 . Anderson stated that selected sensory input can facilitate physiological stability and growth if administered at an early age 5 . Therefore, early intervention is advocated to prevent the occurrence of neurodevelopmental disorders later in life. Individual studies have shown that Yakson touch is able to provide pain relief, improve sleep, affects their behavioural response, decreases the stress levels, increases maternal attachment, and has calming effects 24, 25 . No adverse effects have been noted with Yakson 25 . Tactile kinaesthetic stimulation have been proven to have positive effects on the behaviour of neonates, such as motor development, self-regulated behaviour (regular breathing, state of alertness, balanced tone, a range of postures, coordinated movements, hand-to-face movement control, suction, grip, support, etc.), increased daily weight gain, adaptive behaviour and reduced hospital stay 13, 14 . Medically unstable neonates, or neonates with disease or congenital anomaly are excluded as they will be already impoverished and for them life-saving interventions must be the priority; this too may allow uniformity in the intervention and results of those included. Also, this will avoid any interference in the treatments interventions being given to the already ailing neonate. Neonates with skin infection are excluded as direct touch might be a contraindication for them.
The NBAS is chosen for assessment because it is reliable tool with the inter-rater reliability between 0.85 and 1.00 21 . It also incorporates all components of behaviour and motor development of the neonate. It is a tool for neurological and behavioural assessment capable of detecting any gross abnormality or asymmetry To date there are limited studies on Yakson touch 2, 8, 15 . Therefore this study will aim to determine the combined effect of Yakson touch and Kinaesthetic stimulation on the behaviour of neonates. Should results be favourable it is anticipated that early intervention in the form of Yakson touch and kinaesthetic stimulation is added to the routine treatment of the high-risk neonates.
Conclusion
This protocol details a single centre trial to investigate if YAKIN may improve the behavioural responses of the high-risk neonates and kinaesthetic response may improve the motor behaviour of the highrisk of neonates.
